Setting the stage for participants, providing them with a warm introduction to the vibrant innovation ecosystem of Boston, highlighting key players, industry trends, and opportunities available.

Insights and strategies for approaching stakeholders in the US innovation ecosystem, addressing cultural aspects and best practices for initiating conversations and building relationships

Interactive session where participants pitch their projects in 5 minutes, receiving feedback. It guides participants in creating and delivering effective pitches tailored for a US audience, emphasizing the importance of a compelling core story beyond the investor deck and elevator pitch.

Exploring the unique challenges and unmet needs in pediatric oncology, highlighting key differences from adult cancers. Discussions led by top pediatric oncologists will cover the latest advancements and innovation areas to improve patient outcomes.

Insights into why Boston is recognized as the world's leading life sciences ecosystem. Participants will discover how their businesses can maximize the benefits of this supercluster and capitalize on the opportunities it presents.

Highlighting major research institutions, hospitals, and cancer centers that specialize in pediatric oncology. Discussion on the role these institutions play in advancing pediatric cancer research, from basic science to clinical trials

Key foundations and advocacy groups dedicated to pediatric cancer. How these organizations support research, policy changes, patient access, and public awareness. The importance of collaboration between startups and these entities to drive progress.

Through patients’ personal stories, participants will gain insights into the real-world challenges and the critical need for innovative solutions. This session will inspire participants to keep the patient perspective central to their work, driving forward innovations that make a meaningful difference

Assembling a strategic and well-rounded board is crucial for companies focused on pediatric cancer innovation. Such a board provides the expertise, guidance, and connections necessary to navigate the complex landscape of pediatric oncology effectively.

Key considerations in the design of pediatric oncology trials, including age-specific dosing, safety monitoring, and endpoint selection. Strategies for incorporating innovative trial designs, such as adaptive trials and basket trials, to address the diverse needs of pediatric cancer patients.

Non-traditional fundraising avenues for startups through collaborations with foundations. Participants will delve into a case study highlighting successful partnerships between foundations and startups in childhood cancer.

Overview of the regulatory framework specific to pediatric cancer in the U.S., including the RACE for Children’s Act and other relevant policies. The role of the FDA and other regulatory agencies in supporting the development and approval of pediatric cancer therapies.

Overview of the regulatory framework governing pediatric cancer trials, including the RACE for Children’s Act and relevant FDA guidelines. Ethical considerations specific to pediatric oncology trials, such as informed consent, assent from minor participants, and the balance between risk and benefit.

Profiles of leading biotech, medtech, and digital health companies focused on pediatric cancer. Analysis of recent innovations, clinical trials, and products brought to market by these companies.

Guidance on securing non-dilutive funding in the United States. Participants will learn strategies, tips, and best practices for accessing grants, government funding, and other non-equity sources of financing.

Participants showcase their learnings, action plans, and visionary proposals. This culminating event features insightful feedback and evaluations from both experts and peers, ensuring each participant leaves enriched and empowered. We conclude with a heartfelt farewell event, celebrating our collective journey and the impactful connections forged.

Interactive sessions with successful founders who have transitioned their ventures to the US. Participants will hear firsthand stories and insights about the challenges, opportunities, and lessons learned during the process.

Interactive session where participants pitch their projects in 5 minutes, receiving feedback. It guides participants in creating and delivering effective pitches tailored for a US audience, emphasizing the importance of a compelling core story beyond the investor deck and elevator pitch.

Guidance on creating a compelling investor deck for the US market. Participants will learn strategies to highlight key elements and attract US investors, including market potential, competition analysis, business model, and financial projections

Essential tips and insights for a successful market entry. Led by an experienced accelerator assisting foreign startups, this session covers crucial considerations when landing in the US, offering practical guidance for launching in the region.

Concise legal guidance for preparing a company to establish a presence in the United States.

Insights into the immigration regulations in the United States. This session covers key aspects of immigration law, visa requirements, and processes for individuals and companies.

Participants have several 20-minute meetings with experts who provide feedback and advice on their strategy, including hypotheses validation, road to market, funding and business strategy, clinical trials, reimbursement, and more.